Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
4.860
+0.010 (0.21%)
At close: Apr 28, 2026, 4:00 PM EDT
4.900
+0.040 (0.82%)
After-hours: Apr 28, 2026, 4:16 PM EDT
Absci Employees
Absci had 140 employees as of December 31, 2025. The number of employees decreased by 17 or -10.83% compared to the previous year.
Employees
140
Change (1Y)
-17
Growth (1Y)
-10.83%
Revenue / Employee
$20,000
Profits / Employee
-$822,736
Market Cap
743.68M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ProKidney | 231 |
| CorMedix | 191 |
| Rigel Pharmaceuticals | 174 |
| Prime Medicine | 146 |
| Ocugen | 116 |
| Adlai Nortye | 109 |
| Aclaris Therapeutics | 73 |
| Prothena Corporation | 67 |
ABSI News
- 5 days ago - Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026 - GlobeNewsWire
- 12 days ago - Absci Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 20 days ago - Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Absci Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 7 weeks ago - Absci Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer - GlobeNewsWire